Who invested in ArriVent

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 6 months ago

Funding summaryUpdated 26 Oct 2026

$325Mraised across 2 rounds since 2025, from 2 sources

$75MRound$250MRound

Latest round: Round, $250MMay 2026
Step-upi: 3.3×
Investors: 5

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026

$75MRound$250MRound

First round: Round, $75M
Biggest round: $250M
Between rounds: 10 months

The rounds

May 2026
Round$250M5 returning
Source recorded
Jul 2025
Round$75M5 new
Source recorded

Founders and team

From ArriVent's own website: 3 on the team.

Brent RiceChief Commercial Officer
Chris NoletDirector
Kristine PetersonLead Independent Director

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2025Round2026

General Catalyst

HSG

Hill House CapitalLilly Asia Ventures

Catalio Capital Management

Everyone who backed them

General CatalystVC firm2rounds

HSGVC firm2rounds

Hill House CapitalFamily office2rounds

Lilly Asia VenturesVC firm2rounds

Catalio Capital ManagementVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists ArriVent as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.